Oral-Systemic Link: Page 47

Galera raises $37M to develop treatment for mucositis
By DrBicuspid.com staff writers
Biotech company Galera Therapeutics has raised $37 million in funding to support the development of a treatment to prevent oral mucositis in head and neck cancer patients receiving chemoradiation therapy.
October 15, 2015
Biotech start-up gets $1.5M to develop HNC treatment
By DrBicuspid.com staff writers
Biotech start-up SuviCa has been awarded about $1.5 million from the National Cancer Institute to develop novel treatments for head and neck cancer (HNC).
October 15, 2015
Dara Biosciences launches tablet to treat oral thrush
By DrBicuspid.com staff writers
Pharmaceutical company Dara BioSciences has launched its Oravig tablet to treat oral thrush for the U.S. oncology and primary care markets.
October 5, 2015
Vigilant appoints new VP of commercialization
By DrBicuspid.com staff writers
Vigilant Biosciences has announced the appointment of James McMenamy as vice president of commercialization.
October 4, 2015
UNC researcher, biotech firm partner on rapid oral HPV test
By DrBicuspid.com staff writers
A University of North Carolina (UNC) researcher and a California-based biotechnology company are partnering to create a rapid oral test for HPV.
October 1, 2015
UbiVac, J &J to develop oral cancer vaccine
By DrBicuspid.com staff writers
Biotechnology company UbiVac will collaborate with Johnson & Johnson (J&J) Innovation to develop and test an oral cancer vaccine.
September 29, 2015
Can a laser detect oral cancer?
By Donna Domino
Lasers may soon be used to detect oral cancer, replacing invasive biopsies, according to a University of California researcher who has developed a low-cost, simple device using optical coherence tomography to analyze oral lesions.
September 23, 2015
2014 06 19 10 46 55 930 Laser Red Beams 200
HPV vaccine could eliminate recurrent oral papillomas
By Donna Domino
The HPV vaccine could eliminate recurrent oral squamous cell papillomas, according to a new case report in JAMA Dermatology. An immunocompetent patient with chronic oral warts was cleared of all lesions three months after receiving the quadrivalent HPV vaccine.
September 22, 2015
2014 08 25 16 33 23 1 Hpv Virus Nih 200
Salivary Test for Oral Cancer Now Available
Oral squamous cell carcinoma (OSCC) is the sixth leading cancer worldwide and the fourth in African-American men. The mortality of this disease has not significantly improved in decades and this is largely due to late diagnosis. A new salivary test can help improve these statistics.
September 22, 2015
2015 09 23 07 04 57 32 200x200 Perirx
Oral Cancer Foundation announces fall events
By DrBicuspid.com staff writers
The Oral Cancer Foundation has announced its fall 2015 Walk for Awareness events.
September 21, 2015
Oral Cancer & Diagnostics Insider: Can lasers detect oral cancer?
By Donna Domino
September 16, 2015
NCI renews $10.9M grant for Pitt cancer research
By DrBicuspid.com staff writers
The National Cancer Institute (NCI) has renewed a five-year, $10.9 million grant to the University of Pittsburgh (Pitt) Cancer Institute (UPCI) to continue its research on head and neck cancer.
September 14, 2015
Previous Page
Page 47 of 151
Next Page